Abacus Global Management, Inc. operates as an alternative asset manager and market maker in the United States. It operates through five segments: Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. The Active Management segment is involved in buying, selling, and trading policies and maintaining policies until receipt of death benefits. The Originations segment originates life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owners. The Asset Management segment provides asset management services to investors investing in alternative investment and equity portfolio funds based on fund investment agreements. The Portfolio Servicing segment offers policy services to customers on a contract basis. The Technology Services segment provides real-time mortality verification, missing participant verification, and other services specific to the life insurance market services to customers on a contract basis. It sells its products through financial advisors or agents, direct to consumer, and traditional life settlements intermediaries. The company was formerly known as Abacus Life, Inc. and changed its name to Abacus Global Management, Inc. in February 2025. Abacus Global Management, Inc. was founded in 2004 and is headquartered in Orlando, Florida.

Abacus Life Inc.

Maxim Group analyst Michael Diana reiterated a Buy rating on Abacus Life today and set a price target of $14.00. Diana covers the Financial sector,...

Abacus Life (ABL) Gets a Buy from Maxim Group

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on N-able (NABL – Research Report) and CyberArk Softw...

Analysts Conflicted on These Technology Names: N-able (NABL) and CyberArk Software (CYBR)

TD Cowen analyst Josh Jennings reiterated a Buy rating on Abbott Laboratories today and set a price target of $145.00. The company’s shares opened ...

Current Quarter	$0.2	Next Quarter	$0.23
Current Year	$0.82	Next Year	$0.99
QoQ Growth	+15.0%	YoY Growth	+20.7%
3Y EPS CAGR	N/A	Target Price	$13.10
Consensus	Buy	Upside	+125.5%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ABL	$5.81	+3.38%	600.14K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ABL	$5.81	+3.4%	600.14K
3
4
5
6

ABL

ABL

EPS Estimates Overview

Quarterly EPS Estimates

Revenue Analysis

Get Abacus Life Inc. Data in Excel

Get Abacus Life Inc. Data in Excel